Gapping up
In reaction to strong earnings/guidance: PTN +25.5%, GALT +9.3%, AYA +7.4%, KGJI +6.5%, PLCE +6.3%, MOMO +4.9%, A +4.2%, RENN +4.1%, HIMX +3.1%, TJX +3.0%, MXPT +2.5%, MTH +2.4%, VOD +2.4%, ATV +2.3%, ARP +2.2%, CYRN +1.7%, AKRX +1.6%, AMCN +1.6%, ASM +1.2%
M&A news: NQ +13% (enters definitive agreement for the sale of its entire stake in FL Mobile Jiutian Technology to Shenzhen Prince New Materials for an all-cash consideration of RMB 3243.5 mln), DANG +3.9% (receives revised going-private offer from Chairwoman and CEO for $6.50/share (Lowered from $7.812/share))
Select metals/mining stocks trading higher: VALE +2.6%, AG +2.4%, FCX +1.9%, MUX +1.9%, CLF +1.7%, BHP +1.6%, BBL +1.5%, RIO +0.8%
Select oil/gas related names showing strength: SDRL +1.9%, CHK +1.5%, PBR +1.4%, MRO +0.9%, WLL +0.8%
Other news: NETE +67.1% (opted to exchange the second tranche in the aggregate amount of $250k for 917,431 shares of common stock; co also provided Q1 results in 10-Q), NQ +13% (enters definitive agreement for the sale of its entire stake in FL Mobile Jiutian Technology to Shenzhen Prince New Materials for an all-cash consideration of RMB 3243.5 mln), GALT +9.9% (announces 'positive' interim results from Phase 2a clinical trial with GR-MD-02), BSI +8.5% (Court decision to uphold decision by Trustees of Mega Retail to sell Mega Retail to Bitan Wines), P +4.5% (Corvex Management discloses 9.95% active stake; issues letter to shareholders), CYTX +4.1% (will present an update regarding the use of its Cytori CEll Therapy in the French SCLERADEC I and II clinical trials), VRX +2.5% (updates on regulator matters; continues to expect to make the Canadian Required Filings on or before June 10, 2016)
Analyst comments: FCX +2.1% (upgraded to Buy from Hold at Jefferies), AIG +0.8% (upgraded to Outperform from Market Perform at Wells Fargo), HSBC +0.8% (upgraded to Buy from Hold at Investec), MCHP +0.7% (initiated with a Buy at Credit Agricole)
In reaction to strong earnings/guidance: PTN +25.5%, GALT +9.3%, AYA +7.4%, KGJI +6.5%, PLCE +6.3%, MOMO +4.9%, A +4.2%, RENN +4.1%, HIMX +3.1%, TJX +3.0%, MXPT +2.5%, MTH +2.4%, VOD +2.4%, ATV +2.3%, ARP +2.2%, CYRN +1.7%, AKRX +1.6%, AMCN +1.6%, ASM +1.2%
M&A news: NQ +13% (enters definitive agreement for the sale of its entire stake in FL Mobile Jiutian Technology to Shenzhen Prince New Materials for an all-cash consideration of RMB 3243.5 mln), DANG +3.9% (receives revised going-private offer from Chairwoman and CEO for $6.50/share (Lowered from $7.812/share))
Select metals/mining stocks trading higher: VALE +2.6%, AG +2.4%, FCX +1.9%, MUX +1.9%, CLF +1.7%, BHP +1.6%, BBL +1.5%, RIO +0.8%
Select oil/gas related names showing strength: SDRL +1.9%, CHK +1.5%, PBR +1.4%, MRO +0.9%, WLL +0.8%
Other news: NETE +67.1% (opted to exchange the second tranche in the aggregate amount of $250k for 917,431 shares of common stock; co also provided Q1 results in 10-Q), NQ +13% (enters definitive agreement for the sale of its entire stake in FL Mobile Jiutian Technology to Shenzhen Prince New Materials for an all-cash consideration of RMB 3243.5 mln), GALT +9.9% (announces 'positive' interim results from Phase 2a clinical trial with GR-MD-02), BSI +8.5% (Court decision to uphold decision by Trustees of Mega Retail to sell Mega Retail to Bitan Wines), P +4.5% (Corvex Management discloses 9.95% active stake; issues letter to shareholders), CYTX +4.1% (will present an update regarding the use of its Cytori CEll Therapy in the French SCLERADEC I and II clinical trials), VRX +2.5% (updates on regulator matters; continues to expect to make the Canadian Required Filings on or before June 10, 2016)
Analyst comments: FCX +2.1% (upgraded to Buy from Hold at Jefferies), AIG +0.8% (upgraded to Outperform from Market Perform at Wells Fargo), HSBC +0.8% (upgraded to Buy from Hold at Investec), MCHP +0.7% (initiated with a Buy at Credit Agricole)